MichBio Member News

LexaMed is proud to announce the launch of its newly enhanced and updated website, www.lexamed.net.  The redesigned website has new navigational tools that facilitate easier access to the website's expanded content and graphics that highlight LexaMed's continuously expanding services, products and capabilities.  Now you can also find, browse and/or become a LexaMed fan on Facebook!

Birds do it, bees do it. Even scientists in labs do it. But the scientists can’t hold a candle to the birds and the bees, who can make gobs of primo DNA without even thinking about it.

DNA is a critical element of gene therapy, and scientists working to develop cures for diseases make it with synthesizers. Unfortunately, synthesizers don’t do nearly as good a job as cells in stringing nucleic acids together to make DNA, and many of the resulting sequences—called truncated DNA—are too short and must be discarded.

A new study finds that African ancestry is linked to triple-negative breast cancer, a more aggressive type of cancer that has fewer treatment options.

Researchers at the University of Michigan Comprehensive Cancer Center found that, among women with breast cancer, 82% of African women were triple negative, 26% of African-Americans were and 16% of white Americans were.

Triple negative breast cancer is negative for three specific markers that are used to determine treatment: the estrogen receptor, the progesterone receptor and HER-2/neu.

Neogen Corporation announced that its net income for its 2010 fiscal year, which ended May 31, increased 26% from the previous year to $17,521,000. Net income in the fiscal year increased to $0.76 per share, compared to the prior year’s $0.61, adjusted for a 3-for-2 stock split that was effective Dec. 15, 2009.

Click here to read about Caraco's latest generics offerings, posted in the Great Lakes Innovation and Technology Report.

A multi-disciplinary team of expert investigators from Oakland University and Beaumont Hospitals has begun a research study designed to support the development of a motion monitoring system that helps prevent fall-related injuries among the elderly.

Click here to read this article, which was posted in the July 13, 2010 edition of the Great Lakes Innovation and Technology Report.

Cardiologists at Beaumont Hospital in Royal Oak were the first in Michigan to use a new investigational laser device that may improve long-term effectiveness of ablation, a procedure for treating a common heart rhythm condition called atrial fibrillation.

Beaumont researchers are part of a national, Food and Drug Administration-approved trial studying the safety and effectiveness of the CardioFocus cardiac laser ablation device. The balloon catheter uses a rotating laser to burn heart tissue.

Controlling powerful emotional reactions is often difficult because the brain's computer has a separate "keyboard" that controls feelings within extreme emotions like desire and dread, according to University of Michigan psychologists.

A new study by U-M researchers Kent Berridge, Jocelyn Richard and Alexis Faure (now at the University of Paris-Sud in France) found that a "surprising limitation of top-down signals to penetrate emotion may restrict the voluntary efforts by people to effectively regulate their emotions."